Abstract:NLRP3 activation maintains homeostasis of gut microbiota and intestinal epithelial barrier and reduces liver injury in alcoholic liver disease mice. Meanwhile, after oral infection with V. vulnificus, ALD mice did not induce further activation of NLRP3 inflammasomes, leading to disruption of the intestinal epithelial barrier and eventual bloodstream infection. Background Alcoholic liver disease (ALD) patients with bacterial infections usually exhibit high mortality rates. Infections frequently involve bacteria such as Vibrio vulnificus and Enterococcus faecalis. Nevertheless, the mechanisms predisposing ALD patients to bacterial infections and the role of the NLRP3 inflammasome in the intestinal epithelial barrier in ALD remain unclear. Methods We established ALD mice models of WT, Nlrp3−/− and Gsdmd−/− through chronic alcohol consumption feeding and acute alcohol induction. We compared alterations in gut microbiota, ileitis, and adhesion protein expression, to analyze the role and potential mechanism of NLRP3 in the early onset of ALD. Concurrently, we examined the changes in inflammation and liver damage in the ileum of ALD and healthy mice following foodborne infection with V. vulnificus. Results Compared with the control group, the expression levels of ZO‐1, Claudin‐1 and E‐cadherin were reduced in the ileum of ALD mice, while those of NLRP3, caspase‐1(p20), GSDMD‐N and IL‐1β were elevated. Nlrp3−/− and Gsdmd−/− ALD mice showed an increased gut bacterial load, decreased ileal expression of E‐cadherin, more severe ileitis, pronounced liver damage, steatosis and higher plasma levels of FITC‐dextran, D‐LA and ZO‐1 compared with WT mice. Notably, Nlrp3−/− ALD mice exhibited a higher presence of Deferribacterota and Enterobacteriaceae. Furthermore, ALD mice infected with V. vulnificus infection exhibited no further activation of NLRP3 in the ileum, leading to increased intestinal permeability and bloodstream infections. Conclusions This study indicated that NLRP3 activation in the ileum of ALD mice stabilizes the inflammation‐related gut microbiota, preserves the intestinal epithelial barrier, and diminishes inflammation and liver injury. Furthermore, the compromised immune defence in ALD mice may contribute to their heightened susceptibility to bacterial pathogens. Key points Activation of the NLRP3‐GSDMD pathway in the ileum of Alcoholic liver disease (ALD) mice. NLRP3 activation maintains homeostasis of gut microbiota and intestinal epithelial barrier in ALD mice. ALD mice infected with V. vulnificus infection exhibited no further activation of NLRP3 in the ileum, leading to increased intestinal permeability and bloodstream infections.

Alcohol-induced Liver Injury is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice.

NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease

Invariant NKT Cells Promote Alcohol-Induced Steatohepatitis Through Interleukin-1Β in Mice.

NLRP3 activation maintains intestinal epithelial barrier and reduces liver injury in alcoholic liver disease mice

NLRP12 negatively regulates EtOH-induced liver macrophage activation via NF-κB pathway and mediates hepatocyte apoptosis in alcoholic liver injury

NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis

IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages.

A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease

Selective Inhibition of the NLRP3 Inflammasome Protects Against Acute Ethanol-Induced Cardiotoxicity in an FBXL2-dependent Manner.

Mice lacking α4 nicotinic acetylcholine receptors are protected against alcohol-associated liver injury

The Role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.

NLRP3 inflammasome in hepatic diseases: A pharmacological target

Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease

Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo

Deficiency of NLR family member NLRC5 alleviates alcohol induced hepatic injury and steatosis by enhancing autophagy of hepatocytes

386 Dietary Saturated and Unsaturated Fat Differentially Modulate Gut Microbiome, Intestinal Barrier and Liver Injury in a Mouse Model of Alcoholic Liver Disease

NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in mice

Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice

Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis

IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease